ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Nobelpharma Signs License Agreement to Use ProBioGen’s Vaccine Production Platform
August 13, 2021The cell-based system for vaccine production offers a cost-effective, efficient and flexible alternative to traditional vaccine production. -
Nobelpharma Signs a License Agreement for ProBioGen’s Vaccine Manufacturing Platform AGE1.CR.pIX®
August 13, 2021ProBioGen is pleased to announce that Nobelpharma has signed a license agreement for the use of the AGE1.CR.pIXvaccine production platform to develop their lead vaccine. -
ProBioGen, Nobelpharma Enter Mfg. Agreement for Vax Project
March 25, 2021ProBioGen AG signed a service agreement for Nobelpharma’s vaccine project leveraging ProBioGen’s vaccine development platform consisting of its AGE1.CR.pIX suspension cell line and its high performance cell culture medium, for the propagation of ...
Pharma Sources Insight January 2025
